Author:
Luo Wei,Liu Qianhuang,Zhou Yuxuan,Ran Yiding,Liu Zhaoyin,Hou Weitao,Pei Sen,Lai Shengjie
Abstract
Abstract
Background
The US confronted a “triple-demic” of influenza, respiratory syncytial virus (RSV), and COVID-19 in the winter of 2022, leading to increased respiratory infections and a higher demand for medical supplies. It is urgent to analyze these epidemics and their spatial-temporal co-occurrence, identifying hotspots and informing public health strategies.
Methods
We employed retrospective and prospective space-time scan statistics to assess the situations of COVID-19, influenza, and RSV in 51 US states from October 2021 to February 2022, and from October 2022 to February 2023, respectively. This enabled monitoring of spatiotemporal variations for each epidemic individually and collectively.
Results
Compared to winter 2021, COVID-19 cases decreased while influenza and RSV infections significantly increased in winter 2022. We found a high-risk cluster of influenza and COVID-19 (not all three) in winter 2021. In late November 2022, a large high-risk cluster of triple-demic emerged in the central US. The number of states at high risk for multiple epidemics increased from 15 in October 2022 to 21 in January 2023.
Conclusions
Our study offers a novel spatiotemporal approach that combines both univariate and multivariate surveillance, as well as retrospective and prospective analyses. This approach offers a more comprehensive and timely understanding of how the co-occurrence of COVID-19, influenza, and RSV impacts various regions within the United States. Our findings assist in tailor-made strategies to mitigate the effects of these respiratory infections.
Funder
National University of Singapore FY2020 START-UP GRANT
National Institute for Health
Bill & Melinda Gates Foundation
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference40 articles.
1. Scudellari M. How the pandemic might play out in 2021 and beyond. Nature. 2020;22–5.
2. Lai S, Ruktanonchai NW, Zhou L, Prosper O, Luo W, Floyd JR, Wesolowski A, Santillana M, Zhang C, Du X, Yu H. Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature. 2020;585(7825):410–3.
3. Hu T, Wang S, Luo W, Zhang M, Huang X, Yan Y, Liu R, Ly K, Kacker V, She B, Li Z. Revealing public opinion towards COVID-19 vaccines with Twitter data in the United States: spatiotemporal perspective. J Med Internet Res. 2021;23(9):e30854.
4. Flu RSV. and COVID: Understanding Today’s ‘Tripledemic’ [Internet]. [cited 2023 Feb 6]. Available from: https://www.bu.edu/sph/news/articles/2022/rsv-flu-and-covid-19-understanding-todays-tripledemic/.
5. Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, Nesdale A, Dowell T, Turner N, Campbell-Stokes P. Impact of the COVID-19 nonpharmaceutical interventions on Influenza and other respiratory viral Infections in New Zealand. Nat Commun. 2021;12(1):1001.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献